ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,828,000 | +84.5% | 125,790 | -2.9% | 0.01% | +100.0% |
| Q1 2019 | $3,158,000 | +94.7% | 129,540 | +13.8% | 0.00% | +50.0% |
| Q4 2018 | $1,622,000 | +4405.6% | 113,870 | +4725.0% | 0.00% | – |
| Q3 2018 | $36,000 | -12.2% | 2,360 | -2.3% | 0.00% | – |
| Q2 2018 | $41,000 | -97.1% | 2,415 | -97.2% | 0.00% | -100.0% |
| Q1 2018 | $1,390,000 | +4533.3% | 85,147 | +3507.9% | 0.00% | – |
| Q4 2017 | $30,000 | +3.4% | 2,360 | 0.0% | 0.00% | – |
| Q3 2017 | $29,000 | -98.2% | 2,360 | -98.8% | 0.00% | -100.0% |
| Q2 2017 | $1,594,000 | -11.7% | 190,488 | -5.7% | 0.00% | 0.0% |
| Q1 2017 | $1,806,000 | +0.3% | 202,067 | -1.4% | 0.00% | 0.0% |
| Q4 2016 | $1,801,000 | +19911.1% | 204,870 | +15659.2% | 0.00% | – |
| Q3 2016 | $9,000 | +12.5% | 1,300 | -37.5% | 0.00% | – |
| Q2 2016 | $8,000 | +33.3% | 2,081 | -1.4% | 0.00% | – |
| Q1 2016 | $6,000 | -80.0% | 2,111 | -70.2% | 0.00% | – |
| Q4 2015 | $30,000 | -9.1% | 7,083 | 0.0% | 0.00% | – |
| Q3 2015 | $33,000 | -34.0% | 7,083 | +0.4% | 0.00% | – |
| Q2 2015 | $50,000 | +2.0% | 7,057 | +5.2% | 0.00% | – |
| Q1 2015 | $49,000 | +53.1% | 6,711 | 0.0% | 0.00% | – |
| Q4 2014 | $32,000 | +39.1% | 6,711 | 0.0% | 0.00% | – |
| Q3 2014 | $23,000 | -25.8% | 6,711 | 0.0% | 0.00% | – |
| Q2 2014 | $31,000 | -3.1% | 6,711 | 0.0% | 0.00% | – |
| Q1 2014 | $32,000 | 0.0% | 6,711 | +6.5% | 0.00% | – |
| Q4 2013 | $32,000 | -17.9% | 6,300 | 0.0% | 0.00% | – |
| Q3 2013 | $39,000 | +34.5% | 6,300 | 0.0% | 0.00% | – |
| Q2 2013 | $29,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |